The expression of MMP-2, MMP-7, MMP-9, and TIMP-1 in chronic rhinosinusitis and nasal polyposis

被引:64
作者
Can, Ilknur Haberal [1 ]
Ceylan, Kursat [1 ]
Caydere, Muzaffer [2 ]
Samim, Ethem Erdal [1 ]
Ustun, Huseyin [2 ]
Karasoy, Durdu Sertkaya [3 ]
机构
[1] Minist Hlth Ankara Educ & Training Hosp, ENT Clin, Ankara, Turkey
[2] Minist Hlth Ankara Educ & Training Hosp, Pathol Clin, Ankara, Turkey
[3] Hacettepe Univ, Dept Stat, Ankara, Turkey
关键词
D O I
10.1016/j.otohns.2008.04.032
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 [耳鼻咽喉科学];
摘要
OBJECTIVES: To investigate the expression and clinical significance of MMP-2, MMP-7, MMP-9, and TIMP-1 in patients with nasal polyposis (NP) and chronic rhinosinusitis (CRS). STUDY DESIGN: Prospective study. SUBJECTS AND METHODS: This study involved 54 patients. There were three groups: nasal polyposis group, chronic rhinosinusitis group, and control group. Specimens were collected during endoscopic sinus surgery. Each sample was immunohistochemically examined. RESULTS: Expression of MMP-2 was found significantly increased in NP, whereas MMP-7 expression was found significantly increased in CRS (P < 0.001). TIMP-1 was significantly high in control group compared to CRS and NP (P < 0.001 and P= 0.002, respectively). CONCLUSIONS: Different regulation type of activation of MMPs has been found in these two diseases. If MNIP-2 expression is intense in the mucosa, then this ends with polyp formation; if MMP-7 expression is intense, it ends with CRS or stays as CRS. (C) 2008 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.
引用
收藏
页码:211 / 215
页数:5
相关论文
共 20 条
[1]
Pharmacologic and genetic manipulation of MMP-2 and-9 affects retinal neovascularization in rodent models of OIR [J].
Barnett, Joshua M. ;
McCollum, Gary W. ;
Fowler, Jessica A. ;
Duan, James J. -W. ;
Kay, Jesse D. ;
Liu, Rui-Qin ;
Bingaman, David P. ;
Penn, John S. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2007, 48 (02) :907-915
[2]
Tissue inhibitor of metalloproteinase-1 deficiency abrogates obliterative airway disease after heterotopic tracheal transplantation [J].
Chen, P ;
Farivar, AS ;
Mulligan, MS ;
Madtes, DK .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2006, 34 (04) :464-472
[3]
Cho HJ, 2007, J BIOCHEM MOL BIOL, V40, P1069
[4]
Matrix metalloproteinases as valid clinical targets [J].
Fingleton, Barbara .
CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (03) :333-346
[5]
French J J, 2005, HPB (Oxford), V7, P289, DOI 10.1080/13651820510042246
[6]
Matrix metalloproteinase inhibitors: Current developments and future perspectives [J].
Hoekstra, R ;
Eskens, FALM ;
Verweij, J .
ONCOLOGIST, 2001, 6 (05) :415-427
[7]
Inhibitory Effects of Green Tea Catechins and Lignans on the Activity of Human Matrix Metalloproteinase 7 (MMP-7) and Insights into Their Structure-Activity Relationship [J].
Inouye, K. ;
Oneda, H. ;
Muta, Y. ;
Oyama, S. ;
Shiihara, M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 :125-125
[8]
A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with mucus hypersecretion [J].
Ko, FWS ;
Diba, C ;
Roth, M ;
McKay, K ;
Johnson, PRA ;
Salome, C ;
King, GG .
CHEST, 2005, 127 (06) :1919-1927
[9]
Lechapt-Zalcman E, 2001, J PATHOL, V193, P233, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH771>3.0.CO
[10]
2-W